PHILADELPHIA--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, has received issuance of U.S. Patent 7,173,102: Facially Amphiphilic Polymers as Anti-Infective Agents.
